Advertisement
Advertisement

CLDI

CLDI logo

Calidi Biotherapeutics, Inc.

1.63
USD
Sponsored
+0.01
+0.62%
Aug 10, 15:58 UTC -4
Closed
exchange

After-Market

1.65

+0.02
+1.23%

Calidi Biotherapeutics, Inc. Profile

About

Calidi Biotherapeutics Inc. is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer with a novel stem cell-based therapy. Calidi Biotherapeutics Inc., formerly known as First Light Acquisition Group, is based in SAN DIEGO.

Info & Links

CEO

Eric Poma

Headquarters

4475 EXECUTIVE DRIVE, SUITE 200
SAN DIEGO, CA 92121, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://calidibio.com

Auditor

Marcum llp

Share holders

1

Employees

29

Calidi Biotherapeutics, Inc. Statistics

Valuation Measures

Market Capitalization2

4.03M

Enterprise Value

-1.70M

Enterprise Value/EBITDA(ttm)

0.10

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.24

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-424.58%

Return on Invested Capital(ttm)

-425.22%

Return on Assets(ttm)

-182.38%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-17.68M

Net Income Available to Common(ttm)

-25.01M

Diluted EPS(ttm)

-83.20

Share Statistics

Beta (5Y Monthly)

1.33

52-Week Change

-97.97%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

1.21M

Dividend Yield

0.00%

Float4

1.16M

% Held by Insiders

4.30%

% Held by Institutions

12.53%

Balance Sheet

Total Cash(mrq)

6.63M

Total Cash Per Share(mrq)

5.49

Total Debt(mrq)

901.00K

Total Debt/Equity(mrq)

18.26%

Current Ratio(mrq)

1.92%

Quick Ratio(mrq)

1.92%

Book Value Per Share(mrq)

6.70

Cash Flow

Operating Cash Flow Per Share(ytd)

-6.39

Free Cash Flow(ytd)

-4.12M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement